Chris leads Fourth Eon's strategy and growth, drawing on two decades of experience spanning AI, critical infrastructure, and global security. He co-founded and scaled AMPLYFI, a venture-backed AI company partnering with international defense agencies, and previously led disruptive technology assessment and energy policy at BP. Chris serves as a DARPA SWITCH Advisor, Innovate UK Council Member, and Big if True Science Fellow at Renaissance Philanthropy. He holds a BA in History from SUNY New Paltz and an MSc in International & European Politics from the University of Edinburgh.

Gary leads research and development at Fourth Eon. His expertise spans chemistry, molecular biophysics, biosecurity, and sequencing technology. He's spent nearly two decades studying how DNA, RNA, and proteins behave and interact. He is also a Contributing Scholar at the Johns Hopkins Center for Health Security, supporting the Center's work to understand and mitigate global biological risks from advanced AI. Gary holds a BS in Physics from San Jose State University and a PhD in Chemistry from University of California Merced.

James is a founding Scientific Advisor and co-inventor of the adaptive screening method. He is a medical doctor and computational biologist with expertise in biosecurity, evolutionary biology, and genotype-phenotype relationships. James holds a BA in Medical Sciences from Oxford University, an MBBS from Imperial College London, and a PhD in Computational Cancer Genomics from University College London.

Alex is a PhD candidate in Molecular Biophysics at UT Southwestern Medical Center, where she studies the mechanism of membrane fusion using molecular dynamics simulations. As an ERA AIxBio Research Fellow, she applies her background in computational structural biology to the risk of catastrophic biological misuse. Alex holds a BSc in Nanostructure Engineering, an MSc in Physical Chemistry, and an MSc in Medical Biotechnology from the University of Warsaw, and is an alumna of the Fulbright BioLAB Program.

Chris recently completed his DPhil in Biochemistry at the University of Oxford, where he specialized in viral protein dynamics with biomolecular NMR spectroscopy. Chris is now investigating biosecurity risks brought by the rapid development of AI tools, particularly at the interface of structural and computational biology, and is funded by Coefficient Giving's Career Transition Fellowship program. Chris holds a BSc in Biochemistry from Imperial College London and a MSc by Research in Biochemistry from the University of Oxford.

Dustin builds and safeguards Fourth Eon's software and IT systems, combining more than a decade of full-stack and AI engineering with a background in clinical lab science, microbiology, and philosophy. Dustin has shipped production applications, APIs, and cloud automation across healthcare, finance, and energy. He previously worked as a Medical Lab Scientist across hematology, microbiology, clinical chemistry, and blood bank at Children's Hospital Colorado. He has traveled to 45 countries, but it is never enough to satisfy the wanderlust.

Elias recently completed his MSc in Computational Biology and Bioinformatics from ETH Zürich, where he specialized in ML for protein design. He is interested in AI capabilities and biosecurity risk. He has contributed to publications on LLM risks in agriculture and computational methods in ecology. Previously, he worked at McKinsey on geospatial analytics and generative AI for agriculture.

Emi conducts scoping research for biosecurity screening in cloud labs and automated biofoundries at Fourth Eon. She is the founder of Omnyra, an AI-native sequence and protocol screening platform built with the FBI Weapons of Mass Destruction Directorate and the Defense Innovation Unit, and founder of BiofoundryOS, a cross-biofoundry routing layer. Previously, Emi worked as a software engineer at Amazon, consulted for OpenAI and Google DeepMind, and developed cardiovascular modeling tools at Stanford's Cardiovascular Biomechanics Lab. She holds an M.S. in Computer Science and a B.S. in Biology from Stanford University.

Hanna is a PhD student in Mathematical Epidemiology at the University of Warwick, applying ML to syndromic surveillance data for early outbreak detection with the UK Health Security Agency. Beyond this, their biosecurity work includes co-developing an AI Know-Your-Customer tool for DNA providers, scoping a research programme for function-based screening of nucleic acid sequences with the Centre for Long-Term Resilience, and AI-bio threat modelling as a GovAI Winter Fellow. They hold a BSc in Biology and Philosophy from the University of St Andrews.

Ian is a Physics Professor at the University of North Carolina Greensboro, with experience in Physics Education Research and Computational Physics. Driven by a desire to make the world safer, he's diving into the AI-biosecurity nexus, trying to reduce catastrophic pandemic risk by improving DNA synthesis screening methods. Ian holds a PhD in Physics from the University of Massachusetts Amherst.

Isha is a medical student at the University of Cambridge, with an undergraduate degree in Biochemistry. She has research experience in viral genomics and cancer immunology, and is applying her computational background to biosecurity as a SPAR research fellow.

Kamesh is a MATS Summer Fellow at Fourth Eon, where he is working on function-based approaches to nucleic acid synthesis screening. He is a synthetic biologist and protein engineer with experience in genetic code expansion, orthogonal translation systems, noncanonical amino acids, and computational analysis of protein function. Previously, he worked in the George Church lab and at Arizona State University on questions spanning engineered translation, protein function, and the origins and evolution of the genetic code. He holds a PhD in Biological Sciences from National University of Singapore.

Susan leads finance at Fourth Eon. She’s spent over 15 years helping science and technology ventures scale into sustainable organizations. Previously, she served as Senior Investment & Credit Specialist at the UK’s national innovation agency, was founding CFO of a deep-tech company, and built BNP Paribas’ Commodity Finance Credit Execution team in New York. She mentors early-stage biotechnology companies through UF Innovate. Susan holds a BA in International Commerce & French from University College Dublin and an MA in Philosophies of Asia from SOAS, University of London.